Routine workflow in a reference clinical research center in face of COVID-19

Author:

Cardoso Adriana Serdotte Freitas1ORCID,Silva Stella Marys Rigatti1ORCID,Rabelo-Silva Eneida Rejane2ORCID,Umpierre Daniel3ORCID,Sostizzo Luciana da Rosa Zinn1ORCID,Echer Isabel Cristina4ORCID

Affiliation:

1. Hospital de Clínicas de Porto Alegre (HCPA), Brasil

2. Universidade Federal do Rio Grande do Sul (UFRGS), Brasil; Hospital de Clínicas de Porto Alegre (HCPA), Brasil

3. Hospital de Clínicas de Porto Alegre (HCPA), Brasil; Universidade Federal do Rio Grande do Sul (UFRGS), Brasil

4. Universidade Federal do Rio Grande do Sul (UFRGS), Brasil

Abstract

ABSTRACT Objective To develop and validate the content of workflows for trial participants care in a clinical research center during the Covid-19 pandemic. Method development study by consensus of experts carried out from March to July 2020 in southern Brazil. The flowcharts were developed following literature and validated by specialists considering comprehensiveness, clarity and pertinence, obtaining a 100% agreement index on each item of the developed instruments. The study was approved by the Ethics Committee of the institution. Results two flowcharts of care were elaborated and validated: “Flow diagram to conduct protocols with research participant " and "Flow diagram in protocols with research participant with suspected or confirmed COVID-19 infection"; which describes activities to ensure continuity of care. Final considerations a routine workflow can promote the continuity and safety of clinical research protocols. It is expected that the adopted flowcharts in this study can guide other institutions with a similar research profile.

Publisher

FapUNIFESP (SciELO)

Subject

General Medicine

Reference18 articles.

1. Nota Técnica No 14/2020,2020

2. Guidance on conduct of clinical trials of medical products during COVID-19 public health emergency: guidance for industry, investigators, and institutional review boarders,2020

3. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China;Liang W;Lancet Oncol,2020

4. Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China;Zhang L;Ann Oncol,2020

5. The characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China;Zhonghua Liu Xing Bing Xue Za Zhi,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3